%0 Journal Article
%T Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy
%A Hulya Ertas
%A Ozkan Kanat
%J Archive of "World Journal of Clinical Oncology".
%D 2019
%R 10.5306/wjco.v10.i2.52
%K Angiogenesis inhibition
%K Second-line chemotherapy
%K Colorectal cancer
%K Bevacizumab
%K Aflibercept
%K Ramucirumab
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390122/